Attar Rukset, Attar Erkut
Yeditepe University Medical School, İnönü Mah., Kayışdağı Cad., 26 Ağustos Yerleşimi, 34755 Ataşehir/İstanbul, Turkey.
Istanbul University Istanbul Medical School, Topkapı Mh., Millet Caddesi, Çapa, 34093 Fatih/İstanbul, Turkey.
Womens Health (Lond). 2015 Aug;11(5):653-64. doi: 10.2217/whe.15.51. Epub 2015 Aug 28.
Endometriosis is defined as the presence of endometrial gland and stroma outside the uterine cavity. It is an estrogen-dependent disease and is associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. The treatment of endometriosis is conservative or radical surgery, medical therapies or their combination. All currently used hormonally active treatments are effective in the treatment of endometriosis; however, the adverse effects of these hormonal treatments limit their long-term use. Moreover, recurrence rates are high after cessation of therapy, and the treatments have no benefit in endometriosis-associated infertility. Therefore, researchers are working on new treatment modalities with improved side effects, mainly focusing on the molecular targets involved in etiopathogenesis of endometriosis. Here we summarized these novel treatments modalities.
子宫内膜异位症的定义为子宫腔外存在子宫内膜腺体和间质。它是一种雌激素依赖性疾病,与慢性盆腔疼痛、痛经、性交困难和不孕有关。子宫内膜异位症的治疗方法包括保守性或根治性手术、药物治疗或联合治疗。目前所有使用的激素活性治疗方法对子宫内膜异位症均有效;然而,这些激素治疗的不良反应限制了它们的长期使用。此外,治疗停止后的复发率很高,而且这些治疗方法对子宫内膜异位症相关的不孕没有益处。因此,研究人员正在致力于开发副作用更小的新治疗方式,主要聚焦于参与子宫内膜异位症发病机制的分子靶点。在此,我们总结了这些新型治疗方式。